Cargando…

Multiomics Study of a Novel Naturally Derived Small Molecule, NSC772864, as a Potential Inhibitor of Proto-Oncogenes Regulating Cell Cycle Progression in Colorectal Cancer

Colorectal cancer (CRC) is one of the most prevalent malignant tumors, and it contributes to high numbers of deaths globally. Although advances in understanding CRC molecular mechanisms have shed significant light on its pathogenicity, current treatment options, including combined chemotherapy and m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mokgautsi, Ntlotlang, Kuo, Yu-Cheng, Chen, Chien-Hsin, Huang, Yan-Jiun, Wu, Alexander T. H., Huang, Hsu-Shan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856482/ https://www.ncbi.nlm.nih.gov/pubmed/36672275 http://dx.doi.org/10.3390/cells12020340

Ejemplares similares

Comprehensive Omics Analysis of a Novel Small-Molecule Inhibitor of Chemoresistant Oncogenic Signatures in Colorectal Cancer Cell with Antitumor Effects
por: Huang, Tse-Hung, et al.
Publicado: (2021)

Preclinical Evaluation of a Novel Small Molecule LCC-21 to Suppress Colorectal Cancer Malignancy by Inhibiting Angiogenic and Metastatic Signatures
por: Mokgautsi, Ntlotlang, et al.
Publicado: (2023)

Pharmacoinformatics and Preclinical Studies of NSC765690 and NSC765599, Potential STAT3/CDK2/4/6 Inhibitors with Antitumor Activities against NCI60 Human Tumor Cell Lines
por: Lawal, Bashir, et al.
Publicado: (2021)

Network Pharmacological Analysis through a Bioinformatics Approach of Novel NSC765600 and NSC765691 Compounds as Potential Inhibitors of CCND1/CDK4/PLK1/CD44 in Cancer Types
por: Mokgautsi, Ntlotlang, et al.
Publicado: (2021)

In Silico Evaluation of HN-N07 Small Molecule as an Inhibitor of Angiogenesis and Lymphangiogenesis Oncogenic Signatures in Non-Small Cell Lung Cancer
por: Chen, Lung-Ching, et al.
Publicado: (2023)

Anticancer Activities of 9-chloro-6-(piperazin-1-yl)-11H-indeno[1,2-c] quinolin-11-one (SJ10) in Glioblastoma Multiforme (GBM) Chemoradioresistant Cell Cycle-Related Oncogenic Signatures
por: Mokgautsi, Ntlotlang, et al.
Publicado: (2022)

An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential GSK3β/β-Catenin/STAT3/CD44 Suppressor with Anti-Glioblastoma Properties
por: Mokgautsi, Ntlotlang, et al.
Publicado: (2021)

In-Silico Evaluation of Genetic Alterations in Ovarian Carcinoma and Therapeutic Efficacy of NSC777201, as a Novel Multi-Target Agent for TTK, NEK2, and CDK1
por: Khedkar, Harshita Nivrutti, et al.
Publicado: (2021)

mTOR/EGFR/iNOS/MAP2K1/FGFR/TGFB1 Are Druggable Candidates for N-(2,4-Difluorophenyl)-2′,4′-Difluoro-4-Hydroxybiphenyl-3-Carboxamide (NSC765598), With Consequent Anticancer Implications
por: Lawal, Bashir, et al.
Publicado: (2021)

Identification of CDK1, PBK, and CHEK1 as an Oncogenic Signature in Glioblastoma: A Bioinformatics Approach to Repurpose Dapagliflozin as a Therapeutic Agent
por: Chinyama, Harold A., et al.
Publicado: (2023)

Preclinical Identification of Sulfasalazine’s Therapeutic Potential for Suppressing Colorectal Cancer Stemness and Metastasis through Targeting KRAS/MMP7/CD44 Signaling
por: Leung, Wai-Hung, et al.
Publicado: (2022)

Over-expression of the c-myc proto-oncogene in colorectal carcinoma.
por: Smith, D. R., et al.
Publicado: (1993)

Activation of Cell Cycle Arrest and Apoptosis by the Proto-Oncogene Pim-2
por: Levy, Daphna, et al.
Publicado: (2012)

PBF, a Proto-oncogene in Esophageal Carcinoma
por: Lian, Shi-hai, et al.
Publicado: (2019)

Main Risk Factors Association with Proto-Oncogene Mutations in Colorectal Cancer
por: Dolatkhah, Roya, et al.
Publicado: (2018)

HNC0014, a Multi-Targeted Small-Molecule, Inhibits Head and Neck Squamous Cell Carcinoma by Suppressing c-Met/STAT3/CD44/PD-L1 Oncoimmune Signature and Eliciting Antitumor Immune Responses
por: Lee, Jih-Chin, et al.
Publicado: (2020)

Role of proto-oncogene activation in carcinogenesis.
por: Anderson, M W, et al.
Publicado: (1992)

The Biology of the Ets1 Proto-Oncogene
por: Dittmer, Jürgen
Publicado: (2003)

Analyses of domains and domain fusions in human proto-oncogenes
por: Liu, Qi, et al.
Publicado: (2009)

In Vitro and In Silico Biological Studies of 4-Phenyl-2-quinolone (4-PQ) Derivatives as Anticancer Agents
por: Chen, Yi-Fong, et al.
Publicado: (2023)

Oncogenes, Proto-Oncogenes, and Lineage Restriction of Cancer Stem Cells
por: Brown, Geoffrey
Publicado: (2021)

Ras and Wnt Interaction Contribute in Prostate Cancer Bone Metastasis
por: Lin, Shian-Ren, et al.
Publicado: (2020)

A Novel Compound NSC745885 Exerts an Anti-Tumor Effect on Tongue Cancer SAS Cells In Vitro and In Vivo
por: Chen, Yuan-Wu, et al.
Publicado: (2014)

Expression of ret Proto‐oncogene in Human Neuroblastomas
por: Nagao, Minako, et al.
Publicado: (1990)

Roles of the RET Proto-oncogene in Cancer and Development
por: Takahashi, Masahide, et al.
Publicado: (2020)

A Preclinical Investigation of GBM-N019 as a Potential Inhibitor of Glioblastoma via Exosomal mTOR/CDK6/STAT3 Signaling
por: Wu, Alexander T. H., et al.
Publicado: (2021)

Activation of proto-oncogenes in human and mouse lung tumors.
por: Reynolds, S H, et al.
Publicado: (1991)

The Proto-Oncogene TWIST1 Is Regulated by MicroRNAs
por: Nairismägi, Maarja-Liisa, et al.
Publicado: (2013)

The impact of the MYB-NFIB fusion proto-oncogene in vivo
por: Mikse, Oliver R., et al.
Publicado: (2016)

Distribution of RET proto‐oncogene variants in children with appendicitis
por: Schultz, Jurek, et al.
Publicado: (2022)

Laser nanostructured gold biosensor for proto-oncogene detection
por: Hughes, Cian, et al.
Publicado: (2023)

Potential of DEK proto-oncogene as a prognostic biomarker for colorectal cancer: An evidence-based review
por: Habiburrahman, Muhammad, et al.
Publicado: (2022)

Identification and preclinical evaluation of the small molecule, NSC745887, for treating glioblastomas via suppressing DcR3-associated signaling pathways
por: Fann, Li-Yun, et al.
Publicado: (2017)

MALAT1 regulates the transcriptional and translational levels of proto-oncogene RUNX2 in colorectal cancer metastasis
por: Ji, Qing, et al.
Publicado: (2019)

Regulation of rDNA Transcription by Proto-Oncogene PELP1
por: Gonugunta, Vijay K., et al.
Publicado: (2011)

The expression and significance of proto-oncogene c-fos in viral myocarditis
por: Zhang, Song, et al.
Publicado: (2010)

The proto-oncogene KRAS is targeted by miR-200c
por: Kopp, Florian, et al.
Publicado: (2013)

Identification of Regulatory-RNAs for Alternative Splicing of Ron Proto-Oncogene
por: Moon, Heegyum, et al.
Publicado: (2015)

Characterization of the Promoter Region of the Human c‐kit Proto‐oncogene
por: Yamamoto, Katsuya, et al.
Publicado: (1993)

The human intermediate prolactin receptor is a mammary proto-oncogene
por: Grible, Jacqueline M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2ugujvnvfdaub7i00d2dhrukd0